Medical Device News Magazine
HomeMARKET REPORTS

MARKET REPORTS

Tumor Ablation Market Worth $1.4 Billion

The tumor Ablation Market in terms of revenue was estimated to be worth $0.8 billion in 2024 and is poised to reach $1.4 billion by 2029, growing at a CAGR of 10.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

Global Smart Pills Market to Surge at a CAGR of ~11% by 2030

DelveInsight's Smart Pills Market Insights report provides the current and forecast market analysis, individual leading smart pills companies' market shares, challenges, smart pills market drivers, barriers, trends, and key market smart pills companies in the market.

Global Biotech Investment Report 2024 – Big Biopharma Companies Disruptive Technologies and Portfolio Realignment Will Ensure the Growth Potential of Biotech Investments

The "Growth Opportunities in Global Biotech Investment, 2024" report has been added to ResearchAndMarkets.com's offering.

The Global Biomanufacturing Market Report 2024-2035, with Profiles of 1000+ Companies at the Forefront of Biomanufacturing Innovation

The "Global Biomanufacturing Market 2024-2035" report has been added to ResearchAndMarkets.com's offering.

Global Insulin Delivery Systems Strategic Research Report 2024: Market to Reach $16.8 Billion by 2030

The Insulin Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is projected to reach a revised size of US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030.

Global Nucleic Acid Sample Preparation Industry Research 2023-2033: Emergence of Advanced Stabilization Products, Regulated vs. Multimodal Analysis, Exploring New Applications

The "Nucleic Acid Sample Preparation Market - A Global and Regional Analysis: Focus on Technology, Application, Product, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Respiratory Devices Accessories Market Analysis Report 2023: Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

The "Respiratory Devices Accessories Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.

Comprehensive Market Report Forecasts Digital Caries Detection Devices Market Growth to 2033, Accentuating Technological Innovations and COVID-19 Impact

The "Digital Caries Detection Devices Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering

Next-Generation Contraceptives Market

The "Next-Generation Contraceptives Market - A Global and Regional Analysis: Focus on Gender, Offering, End User, and Region - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.

Nanobiotechnology Global Strategic Research Report 2024

The global market for Nanobiotechnology estimated at US$100 Billion in the year 2023, is projected to reach a revised size of US$160.3 Billion by 2030, growing at a CAGR of 7% over the analysis period 2023-2030.
spot_imgspot_img

Recent News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”